ApprovalTrail

Approval · Notice of Compliance 10915 · 2010

APX-ACYCLOVIR: Notice of Compliance 10915

Issued January 13, 2010

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
10915
Date
January 13, 2010
Company
Apotex Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Additional product name
Therapeutic class
Antiviral agent

Products in this notice

BrandDINStatus today
APX-ACYCLOVIR02340739—
APX-ACYCLOVIR02340747—
APX-ACYCLOVIR02340755—

Medicinal ingredients